A detailed history of Jane Street Group, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 138,189 shares of GRTS stock, worth $4,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,189
Previous 703,317 80.35%
Holding current value
$4,145
Previous $436,000 81.65%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.45 - $0.71 $254,307 - $401,240
-565,128 Reduced 80.35%
138,189 $80,000
Q2 2024

Aug 14, 2024

BUY
$0.62 - $2.35 $343,967 - $1.3 Million
554,787 Added 373.52%
703,317 $436,000
Q1 2024

May 15, 2024

SELL
$1.96 - $2.9 $102,805 - $152,110
-52,452 Reduced 26.1%
148,530 $381,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $2.85 $257,256 - $572,798
200,982 New
200,982 $410,000
Q2 2023

Aug 14, 2023

SELL
$1.66 - $3.03 $636,779 - $1.16 Million
-383,602 Reduced 95.75%
17,007 $33,000
Q1 2023

May 15, 2023

BUY
$2.13 - $3.74 $707,049 - $1.24 Million
331,948 Added 483.46%
400,609 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$2.17 - $3.92 $30,141 - $54,448
13,890 Added 25.36%
68,661 $236,000
Q3 2022

Nov 14, 2022

SELL
$2.46 - $4.75 $64,806 - $125,134
-26,344 Reduced 32.48%
54,771 $141,000
Q2 2022

Aug 16, 2022

SELL
$1.77 - $4.34 $266,639 - $653,794
-150,644 Reduced 65.0%
81,115 $196,000
Q1 2022

May 17, 2022

BUY
$4.03 - $12.19 $705,439 - $2.13 Million
175,047 Added 308.66%
231,759 $955,000
Q4 2021

Feb 15, 2022

BUY
$8.76 - $13.71 $143,374 - $224,391
16,367 Added 40.57%
56,712 $730,000
Q3 2021

Nov 16, 2021

BUY
$6.41 - $13.54 $258,611 - $546,271
40,345 New
40,345 $436,000
Q2 2021

Aug 16, 2021

SELL
$8.13 - $10.2 $340,329 - $426,982
-41,861 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$4.07 - $27.11 $170,374 - $1.13 Million
41,861 New
41,861 $395,000
Q4 2020

Feb 17, 2021

SELL
$2.57 - $4.22 $30,642 - $50,315
-11,923 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$2.63 - $8.09 $31,357 - $96,457
11,923 New
11,923 $32,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.